When a patient with renal cell carcinoma (RCC) progresses on or following the combination of a tyrosine kinase inhibitor (TKI ...

We’re starting to understand more that endometrial cancer harbors a number of cell surface markers, including folate receptor ...

Data from the longitudinal ColoCare study (NCT02328677) of patients with colorectal cancer add to a growing body of evidence ...

Transportation is a key accessibility issue for patients with HR-positive metastatic breast cancer receiving CDK4/6 ...

Findings from a real-world, head-to-head comparison show greater colorectal cancer risk reduction and safety with the use of ...

As the renal cell carcinoma (RCC) treatment landscape shifts to more personalized and combinatorial approaches, advanced practice providers (APPs) are key to the safety of patients receiving tyrosine ...

The frontline combination of zanidatamab-hrii (Ziihera) and chemotherapy with or without tislelizumab (Tevimbra) was ...

When we examine vicarious trauma in Latino and other communities of color, we cannot separate individual experience from the ...

Welcome to Onc Nurse On Call, the new podcast from Oncology Nursing News, hosted by editors-in-chief Patricia Jakel, MN, RN, ...

A few years ago, I had a patient who affectionately went by the name “Pops.” At 85 years young, he was full of life and juggling multiple health issues alongside prostate cancer, yet determined not to ...